Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Salusnicar

Approved

STANDARD

Salusnicar

Mason Pharma🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: be431d6b70ea1f90
Company: Mason Pharma
Type: Standard

Approval Details

Approval Id: be431d6b70ea1f90
Drug Approval Philippines Name: Salusnicar
Product Name: Salusnicar
Registration Number: DRP-13161-02
Brand Name: Salusnicar
Generic Name: Nicardipine Hydrochloride
Dosage Form: Solution for IV Infusion
Dosage Strength: 1 mg / mL
Manufacturer: Mason Pharma
Importer: Finstad Inc.
Distributor: Salusa Medical Supplies and Pharmaceuticals Inc
Issuance Date: 24 February 2025
Expiry Date: 12 December 2027
Pharmacologic Category: Calcium Channel Blocker
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

be431d6b70ea1f90

Type

Standard

Back to Philippines FDA Approvals

Salusnicar - Philippines FDA Drug Approval Details